Rex MD Appears in 18.1% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.

Mark HuntleyBy Mark HuntleyFounder and CEO
10 minutes read

Key Takeaways

  • Rex MD was mentioned in 51 of 281 benchmark answers and recommended in 33, but it was ranked first only once.
  • Month-over-month results improved in mentions and recommendations, while top-three and first-place placements declined.
  • No conflicting claims were recorded, so the immediate work is verification and baseline tracking rather than correction.
  • Priority actions focus on company pages, third-party source review, and content built around recurring buyer questions.

Answer Capsule

In November 2026, Rex MD appeared in 51 of 281 AI answers included in the ED Treatment Pills benchmark (18.15%). It received 33 recommendations (11.74%), with 17 Top 3 placements and 1 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.

Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. The historical results show how the figures changed across available months. Different monthly samples limit those comparisons, and conflicting AI claims require verification before corrections are proposed.

Current AI visibility

Questions This Section Answers

  • How do Rex MD mentions, recommendations and placements compare with its ED Treatment Pills peers?

Rex MD recorded 51 mentions (18.15%) and 33 recommendations (11.74%) across 281 answers included in the benchmark. Top 3 placements numbered 17; first-place recommendations numbered 1. Framing among its mentions was 33 positive, 16 neutral and 2 negative.

Rank

Company

Mentions

Mention rate

Recommendations

Recommendation rate

Top 3

Top 3 rate

#1

#1 rate

1

Hims

252

89.68%

189

67.26%

144

51.25%

75

26.69%

2

Ro

237

84.34%

179

63.70%

131

46.62%

20

7.12%

3

GoodRx Care

214

76.16%

168

59.79%

122

43.42%

62

22.06%

4

plushcare

111

39.50%

92

32.74%

40

14.23%

6

2.14%

5

Lemonaid Health

98

34.88%

79

28.11%

28

9.96%

1

0.36%

6

BlueChew

68

24.20%

33

11.74%

16

5.69%

2

0.71%

6

Rex MD

51

18.15%

33

11.74%

17

6.05%

1

0.36%

8

Blink Health

20

7.12%

20

7.12%

12

4.27%

5

1.78%

9

Optum

22

7.83%

17

6.05%

14

4.98%

7

2.49%

10

K Health

17

6.05%

15

5.34%

5

1.78%

1

0.36%

Rex MD appears in a meaningful share of benchmark answers and is recommended in a smaller but still substantial share. The gap between mentions and recommendations matters: being named is not the same as being endorsed, and the client should read reach and endorsement as separate goals.

First-place placement is the weakest part of the picture. Rex MD is recommended far more often than it is ranked first, so answers that do endorse the brand tend to place it behind rivals. Proposed work should focus on what makes an answer choose one option over another, not simply on getting named.

Framing is largely positive or neutral, with few negative mentions. That is a reasonable base, but positive wording alone does not produce recommendations, so the agency should treat sentiment as context rather than as a lever it can pull directly.

What changed since last month

Questions This Section Answers

  • How did Rex MD counts and coverage differ across the available monthly snapshots?

Metric

Oct 2026

Nov 2026

Mentions

43 / 296 (14.53%)

51 / 281 (18.15%)

Recommendations

26 / 296 (8.78%)

33 / 281 (11.74%)

Top 3 recommendations

20 / 296 (6.76%)

17 / 281 (6.05%)

#1 recommendations

6 / 296 (2.03%)

1 / 281 (0.36%)

Only months with verified results are shown. Monthly sample coverage is listed in Methodology.

From October 2026 to November 2026, Rex MD's mention count rose from 43 to 51, while its recommendation count rose from 26 to 33. The recommendation rate was 8.78% and 11.74% respectively.

The recorded month shows more mentions and more recommendations than the prior month, while top-three placements eased and first-place placements fell sharply. These are separate selected samples, so the movement should be read as an observation rather than a trend the agency can attribute to any cause.

The answer samples differ between months, which limits direct comparison of counts and rates. The agency should present the change as recorded movement and keep the comparability caveat beside it, rather than building a narrative around why the numbers moved.

A useful next step is a stable baseline scorecard so future months can be compared on consistent terms. That gives the client a clearer view of direction without overclaiming what any single month shows.

AI recommendation trend

Observed recommendation rate (%), Oct 2026 to Nov 2026

  • Rex MD+2.96 pp
    Oct 20268.78%
    Nov 202611.74%

Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.

/ Take the next step

Want to Understand Your AI Citation Footprint?

We start every engagement with a full audit of how AI systems reference your brand today.

Measurable, Repeatable Programme

Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge

Citation Architecture Review

Identify which high-authority community sources are and aren't working in your favour across AI platforms.

AI Visibility Audit

Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.

Step 1. Measure

Questions This Section Answers

  • What should the agency measure and verify first for Rex MD?

AI answers contained 0 conflicting claims about Rex MD: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No conflicting claims about Rex MD were recorded in the captured answers, so there is no immediate fact-check queue to work through. That is a clean starting position, but it does not confirm that every statement about the company is accurate or current.

The agency would still build a visibility comparison and a short list of claims worth verifying against primary sources. This lets the client see where it stands relative to competitors and where any future discrepancy would need attention, without treating an AI answer as proof of an error.

Keeping that list small and evidence-led avoids wasted effort. Each item would carry an owner and a verification requirement before any correction is considered.

Step 2. Make the website consistent

Questions This Section Answers

  • Which recorded claim differences about Rex MD should be verified before proposed page edits?

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

This part of the analysis returned no results, so there are no disputed topics to resolve for Rex MD at present. The agency would not manufacture a consistency issue where none was recorded.

Instead, the proposed work is a light verification pass: confirm the company entity, dates and sources behind any statement that later surfaces, and only then decide whether a page brief or correction is warranted. Different dates can explain an apparent conflict, so timing needs checking first.

If nothing disputed appears, the client saves effort and the agency can redirect attention to visibility and buyer content. Any future correction would require current primary-source verification before action.

Step 3. Align the external narrative

Questions This Section Answers

  • Which cited third-party pages are relevant to fact review for Rex MD?

Cited page selected for review

Citation appearances in all captured answers

Answers mentioning the company

Conflicting claims linked to this page

https://goodrx.com/sildenafil/viagra-now-available-directly-online

64

11

0

https://healthline.com/health/mens-health/viagra-online

20

11

0

https://bidwellhealth.com/ed-treatment-cost

17

10

0

https://walgreens.com/topic/virtual-healthcare/sexual-health/sildenafil.jsp

54

8

0

https://lemonaidhealth.com/drug/viagra

40

8

0

https://ro.co/erectile-dysfunction/viagra/

40

8

0

These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.

Several third-party pages are cited alongside Rex MD in captured answers, including health information and pharmacy sites. Citation does not establish that a page influenced an answer, and none of these pages is linked to a conflicting claim in the record.

The proposed work is a focused review of the most relevant sources, checking their current contents before any request is made. Where a page is out of date or unclear, the agency would prepare an evidence-backed request rather than assume publisher error or control.

Requests should be tracked separately from responses, with confirmed edits and no-change decisions recorded distinctly. This keeps the client's expectations grounded in what was actually asked and answered.

Step 4. Optimize priority company pages

Questions This Section Answers

  • Which observed Rex MD website pages should receive review briefs?

Company website page

Citation appearances in all captured answers

Benchmark answers citing the page

Recommending answers citing the page

https://rexmd.com/

5

0

0

https://rexmd.com/learn/rexmd-vs-ro-ed-treatment

4

0

0

https://rexmd.com/land/hair/finasteride-gs-gmc/

2

1

0

https://rexmd.com/learn/5-best-telehealth-platforms-for-erectile-dysfunction

2

1

1

https://rexmd.com/learn/how-does-rex-md-work

2

0

0

https://rexmd.com/our-medications/erectile-dysfunction/

2

0

0

https://rexmd.com/faq.php

1

0

0

https://rexmd.com/our-medications/

1

0

0

The company's website was cited 20 times across 9 distinct page addresses; the table shows 8 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.

Rex MD's own site was cited across a small set of pages, but few of those citations appeared in answers that recommended the company. The homepage and a comparison page drew the most appearances, while several product and learning pages drew little or none.

The agency would prepare page briefs for the priority pages using approved company facts and the questions buyers actually ask. Each brief would state what the page should clarify and which claims need sign-off, rather than rewriting pages on assumption.

Because a cited page is not automatically one that accompanied a recommendation, the briefs should aim at usefulness to the reader first. Existing coverage would be checked before proposing new pages.

Step 5. Publish around buyer questions

Questions This Section Answers

  • Which observed buyer questions support content briefs for Rex MD?

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What is the best online ED medication?

3

3

2

What are the best online ED pills?

3

2

2

What is the best online treatment for ED?

3

2

2

Can you really buy Viagra online?

1

1

1

What is the ED pill free trial?

2

1

1

What's the best ED medication online?

3

1

1

What's the best Viagra to buy online?

2

1

1

Where can I get Kamagra to buy?

1

1

1

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

The recorded questions cluster around choosing an online ED medication or treatment, with a smaller set on buying Viagra online, free trials and specific products. Rex MD was mentioned and recommended in several of these, which suggests the brand is already part of the consideration set for these questions.

These are answer observations, not search volume or verified demand. The agency would check existing site coverage before proposing anything new, then draft buyer-question content that answers the question directly and uses approved facts.

Priority should go to the recurring choice questions, where a clear, well-evidenced answer can help both readers and the brand's standing in future answers.

Our 90-day action plan

Questions This Section Answers

  • How should the agency sequence the proposed Rex MD work and judge completion?

Period

Deliverable

Completion criterion

Days 1–30

Baseline scorecard, scoped fact-review register and page/source shortlist

Each record has an owner, evidence requirement and review status

Days 31–60

Approved page briefs and justified publisher requests

Separate confirmed edits, no-change decisions, requests and responses

Days 61–90

Buyer-content briefs and a fresh scorecard

Record work completed separately from measured answer outcomes and comparability limits

The first month establishes the baseline: a scorecard, a scoped fact-review list and a shortlist of pages and sources, each with an owner and review status. This gives later work something concrete to build on.

The second month turns that into approved page briefs and justified publisher requests, with confirmed edits, no-change decisions, requests and responses recorded separately. The third month adds buyer-content briefs and a fresh scorecard.

Delivered work is not the same as a measured visibility outcome. The agency would report completed work separately from answer results, and keep the comparability limits visible so the client does not read the plan as a promise of gains.

Methodology

Questions This Section Answers

  • How are Rex MD answer metrics and citation populations defined?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 281 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 5650 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

Reporting month

Answers included

AI services covered

Services

Oct 2026

296

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

Nov 2026

281

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

July 2026 measured a different set of companies, so it is excluded from this comparison. August 2026 measured a different set of companies, so it is excluded from this comparison. September 2026 measured a different set of companies, so it is excluded from this comparison.

The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.

The benchmark covers a fixed set of answers that met inclusion rules, and a company counts as recommended only when an answer endorses it with positive wording. Top-three and first-place counts sit inside recommendations rather than adding to them.

Answers can mention several companies, so company counts do not sum to distinct answers. Sentiment describes answer wording, not customer satisfaction. The exact collection dates for the original answers are unverified, and cited pages still need independent checking.

Monthly samples differ, so comparisons show how recorded results changed, not why.

Our first three priorities

The first priority is a stable baseline scorecard that separates mentions, recommendations and placement, so the client can track reach and endorsement without conflating them. This directly addresses the gap between being named and being chosen first.

The second is a focused review of the company's priority pages, using approved facts and buyer questions to produce page briefs. Existing coverage should be checked first, and any correction would need current primary-source verification.

The third is buyer-question content around the recurring choice questions, drafted to answer directly and tracked separately from measured answer outcomes. Together these give the client useful work without overclaiming what any single month shows.

/ Learn More

Understanding AI search visibility.

AI search experiences create answers by pulling information from many places online and summarizing it into a single response.

What Is AI Citation Intelligence?
AI citation intelligence is the process of measuring where AI platforms source their information and how frequently a brand is mentioned or referenced in AI-generated responses. Because LLMs synthesize across multiple sources, the sites and brands that appear repeatedly tend to influence how a topic or company is framed. This practice focuses on identifying which sources shape AI outputs and tracking brand visibility across different AI systems.
What Is Citation Architecture?
Citation architecture describes the set of sources that consistently inform how AI systems talk about a brand, product, or topic. LLMs draw from websites, articles, forums, and public discussion, and the sources they rely on most often become the backbone of their answers. Building strong citation architecture means ensuring that accurate, credible, high authority sources are the ones most likely to shape the way AI tools summarize and recommend a brand.
What Is Generative Engine Optimization?
Generative engine optimization (GEO) is the practice of improving the chances that AI systems use and cite your brand or content when generating answers. While traditional SEO is centered on ranking pages in search results, GEO focuses on how LLMs retrieve, interpret, and combine information when responding to a question. The objective is to strengthen the content and sources AI systems rely on, so your brand is treated as a trusted reference in AI responses.
What Is AI Share of Voice?
AI share of voice tracks how often a brand appears in AI-generated answers compared with competitors in the same category. It reflects visibility across AI platforms such as ChatGPT, Gemini, Claude, and Perplexity. Monitoring AI share of voice helps organizations see whether AI systems consistently include and recommend their brand for key queries or whether competitor brands are showing up more often.

About The Author

Mark Huntley

Mark Huntley

Founder and CEO

Mark Huntley, J.D. is founder of CiteWorks Studio, a strategic advisory focused on visibility, authority, and recommendation presence in AI-shaped search environments. His work centers on embedding-level GEO, vector optimization, and cosine gap engineering — helping brands align their digital presence with the retrieval systems that increasingly shape discovery, interpretation, and choice.

Archived editions

Browse earlier published research snapshots for this article. The latest edition remains at the current URL.

VIEW ALL CASE STUDIESREQUEST AN AI VISIBILITY AUDIT